Certain Bisphosphonates Tied to Lower Risk of Endometrial CA

This article originally appeared here.
Share this content:
Certain Bisphosphonates Tied to Lower Risk of Endometrial CA
Certain Bisphosphonates Tied to Lower Risk of Endometrial CA

MONDAY, Dec. 22, 2014 (HealthDay News) -- Bisphosphonates may lower the risk of endometrial cancer, new research suggests. The study appears online Dec. 22 in Cancer.

Researchers examined the medical records of women who took bisphosphonates that contain nitrogen, which is thought to boost antitumor effects. The authors studied 29,254 women overall. When assessing risk, they accounted for factors such as age, race, and smoking status.

The researchers found that women taking the drugs had about half the risk of endometrial cancer compared to women who don't take the drugs. The effect was similar after adjusting for all the covariates in Cox proportional hazards analysis.

"Other studies have shown that bisphosphonates may reduce the risk of certain cancers, but we are the first to show that the risk for endometrial cancer may also be reduced," Sharon Hensley Alford, Ph.D., a public health researcher from the Henry Ford Health System in Detroit, said in a journal news release. "This study suggests that women who need bone-strengthening medications and who have increased risk for endometrial cancer may want to choose the nitrogen form of bisphosphonates because this form may reduce the risk of endometrial cancer."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FDA Panel Has Tie Vote on New Type ...

Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years

Frailty Could Increase Susceptibility for Dementia

Frailty Could Increase Susceptibility for Dementia

Authors say frailty should be considered in clinical care, management of Alzheimer dementia

is free, fast, and customized just for you!




Already a member?

Sign In Now »